Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Teva Enters Into Agreement With OncoGenex
Teva Pharmaceutical (Teva) and OncoGenex Pharmaceuticals (OncoGenex) have entered into a global license and collaboration agreement to develop and commercialise OGX-011, as well as an agreement to purchase
Teva Pharmaceutical (Teva) and OncoGenex Pharmaceuticals (OncoGenex) have entered into a global license and collaboration agreement to develop and commercialise OGX-011, as well as an agreement to purchase
Sanofi-aventis and Chattem have entered into an agreement under which sanofi-aventis is to acquire Chattem for approximately $1.9 billion. Sanofi-aventis also announced that it will seek to convert
ZymoGenetics has reported a restructuring of the US co-promotion and ex-US license and collaboration agreements with Bayer Schering Pharma and Bayer HealthCare relating to Recothrom Thrombin, topical (Recombinant).
AkzoNobel will start the production at its chelates facility located at the company’s new E275m multi-site in Ningbo, China, this week. The company now claims itself to be
Agios Pharmaceuticals (Agios) has received funding from Accelerate Brain Cancer Cure (ABC2). ABC2’s funding will enable new research investigating IDH1 gene mutations in brain cancer, with the goal
Durata Therapeutics (Durata) has acquired Vicuron Pharmaceuticals (Vicuron) from Pfizer (PFE). Durata is a newly formed biopharmaceutical company that was created to pursue late-stage clinical development of novel
XenoTech has introduced its new product in the field of cryopreserved pooled human hepatocytes, CryostaX. The company said that CryostaX is the largest single-freeze pool of cryopreserved human
The FDA has extended the action date for its review of Cephalon’s supplemental New Drug Application (sNDA) for Nuvigil (armodafinil) tablets [C-IV], to March 29, 2010. The sNDA
Radient Pharmaceuticals (Radient) has signed a three-year marketing, sales and distribution agreement with GenWay Biotech. As per the agreement, GenWay Biotech has non-exclusive rights to distribute RPC’s Onko-Sure
The FDA has granted Emergency Use Authorisation (EUA) to TessArae for its TessArray Resequencing Influenza A Microarray Detection Panel for the detection of the 2009 H1N1 Influenza A